Volta
Community-Acquired Pneumonia in Adults
Unknown authors
· 2025
hash_id: a999998a0e9994e7c16568ec42c5eb6500028106fb24eda548290ef6155bd31c
· DOI: 10.1056/evidra2500170
AbstractIn the United States, community-acquired pneumonia (CAP) is estimated to be responsible for 1.2 million emergency department visits and 41,210 deaths annually. This review summarizes the epidemiology, pathophysiology, microbiology, diagnosis, microbiologic testing, pharmacotherapy, and long-term adverse health outcomes for CAP in adults.
Reference & gravity metrics
Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP
Secondary-market trade history
No secondary-market trades recorded for this Volta yet.
References (0)
No outbound references recorded.
Cited by (1)
| Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection | secondary |